These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27825309)

  • 1. Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study.
    Asres A; Jerene D; Deressa W
    BMC Infect Dis; 2016 Nov; 16(1):653. PubMed ID: 27825309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
    Ukwaja KN; Oshi SN; Alobu I; Oshi DC
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):295-301, i-vii. PubMed ID: 25686137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.
    Sinshaw Y; Alemu S; Fekadu A; Gizachew M
    BMC Infect Dis; 2017 Feb; 17(1):132. PubMed ID: 28178936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.
    Manabe YC; Hermans SM; Lamorde M; Castelnuovo B; Mullins CD; Kuznik A
    PLoS One; 2012; 7(6):e39187. PubMed ID: 22723960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delays to anti-tuberculosis treatment intiation among cases on directly observed treatment short course in districts of southwestern Ethiopia: a cross sectional study.
    Asres A; Jerene D; Deressa W
    BMC Infect Dis; 2019 May; 19(1):481. PubMed ID: 31142288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological distress and its effect on tuberculosis treatment outcomes in Ethiopia.
    Tola HH; Shojaeizadeh D; Garmaroudi G; Tol A; Yekaninejad MS; Ejeta LT; Kebede A; Karimi M; Kassa D
    Glob Health Action; 2015; 8():29019. PubMed ID: 26610316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of tuberculosis and its response to anti-TB drugs among tuberculosis patients treated under the TB control programme at Felege-Hiwot Referral Hospital, Ethiopia.
    Zenebe Y; Adem Y; Mekonnen D; Derbie A; Bereded F; Bantie M; Tulu B; Hailu D; Biadglegne F
    BMC Public Health; 2016 Aug; 16():688. PubMed ID: 27485507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
    Ige OM; Sogaolu OM; Odaibo GN; Olaleye OD
    Afr J Med Med Sci; 2004 Sep; 33(3):259-62. PubMed ID: 15819474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.
    Swaminathan S; Menon PA; Gopalan N; Perumal V; Santhanakrishnan RK; Ramachandran R; Chinnaiyan P; Iliayas S; Chandrasekaran P; Navaneethapandian PD; Elangovan T; Pho MT; Wares F; Paranji Ramaiyengar N
    PLoS One; 2012; 7(12):e47400. PubMed ID: 23251327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia.
    Tesfahuneygn G; Medhin G; Legesse M
    BMC Res Notes; 2015 Sep; 8():503. PubMed ID: 26420164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
    Pho MT; Swaminathan S; Kumarasamy N; Losina E; Ponnuraja C; Uhler LM; Scott CA; Mayer KH; Freedberg KA; Walensky RP
    PLoS One; 2012; 7(4):e36001. PubMed ID: 22558301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
    Peetluk LS; Rebeiro PF; Cordeiro-Santos M; Kritski A; Andrade BB; Durovni B; Calvacante S; Arriaga MB; Turner MM; Figueiredo MC; Rolla VC; Sterling TR
    J Infect Dis; 2020 Apr; 221(9):1416-1424. PubMed ID: 31724035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
    Jindani A; Nunn AJ; Enarson DA
    Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of tuberculosis].
    Ben Amar J; Dhahri B; Aouina H; Azzabi S; Baccar MA; El Gharbi L; Bouacha H
    Rev Pneumol Clin; 2015; 71(2-3):122-9. PubMed ID: 25434510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.